The government previously had asked patients receiving immunosuppression for a liver transplant or autoimmune hepatitis to be shielded. As no central register exists for patients with autoimmune hepatitis on immunosuppressive medications, individual hospitals with the help of specialists have been identifying these patients for shielding.
NHS England is asking that both lists of these patients should be passed onto the COVID-19 lead within their hospital by Monday 13th April. They will then pass this information onto NHS England.
Please ensure this information is passed onto the relevant person within your Trust.
Phil Newsome, BSG VP Hepatology